Publication | Closed Access
OA09.01 First-line Nivolumab + Ipilimumab + Chemo in Patients With Advanced NSCLC and Brain Metastases: Results From CheckMate 9LA
23
Citations
0
References
2021
Year
Advanced NsclcBrain MetastasesMedicinePharmacologyImmune Checkpoint InhibitorPharmacotherapyCancer TreatmentOncologyCheckmate 9La
No additional data available for this publication yet. Check back later!